Ayad Hamdan

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Brentuximab vedotin with AVD for stage II–IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trial”.

Brentuximab vedotin with AVD for stage II–IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trial

The Lancet Haematology(2023)10.1016/s2352-3026(23)00157-6

N/A

0.847DataRank · unranked

32 citations

Page C. Moore, Milan Bimali, Jeanette Y. Lee, Michelle A. Rudek, Amy Chadburn +22 more

Changes in Clinical Context for Kaposi's Sarcoma and Non-Hodgkin Lymphoma Among People With HIV Infection in the United States

UNC Libraries(2020)10.17615/g79s-1870

N/A

0DataRank · unranked

0 citations

Anna E. Coghill, Eric A. Engels, Mary E. Ballestas, Ayad Hamdan, Satish Gopal +7 more